Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases

Cell Host and Microbe

Volumn 11, Issue 5, 2012, Pages 447-456

  Casadevall, Arturo ^a   Pirofski, Liise Anne ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 BETA MANNOTRIOSE; AMPHOTERICIN; ASPARTIC PROTEINASE; BETA 1,3 GLUCAN; EFUNGUMAB; FUNGAL PROTEIN; FUNGUS ANTIBODY; FUNGUS ANTIGEN; FUNGUS VACCINE; GLUCOSYLCERAMIDE; GLUCURONOXYLOMANNAN; GLYCOPEPTIDE; GLYCOPHORIN A; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN M; INTERLEUKIN 10; MANNAN; MANNOPROTEIN; MELANIN; MONOCLONAL ANTIBODY; MP58 MANNOPROTEIN; PHOSPHOGLYCERATE KINASE; TETRASPANIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; B LYMPHOCYTE; BIOFILM; CANDIDA ALBICANS; CANDIDIASIS; CELL DEATH; CELL SURVIVAL; COMPLEMENT SYSTEM; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE COURSE; FUNGAL CELL; GENE EXPRESSION; HISTOPLASMA CAPSULATUM; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; LUNG INFECTION; MACACA; MEMORY CELL; MULTICENTER STUDY (TOPIC); MYCOSIS; NATURAL KILLER CELL; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; PATHOGENESIS; PHAGOCYTOSIS; PHAGOSOME; PNEUMOCYSTIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; VAGINA CANDIDIASIS;

ANTIBODIES, FUNGAL; FUNGAL VACCINES; FUNGI; HUMANS; IMMUNOGLOBULINS; IMMUNOTHERAPY; MYCOSES;

FUNGI;

EID: 84861168204     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2012.04.004     Document Type: Review

References (113)

1. J. Abadi, and L. Pirofski Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without human immunodeficiency virus infection J. Infect. Dis. 180 1999 915 919
2. K. Agematsu, H. Nagumo, K. Shinozaki, S. Hokibara, K. Yasui, K. Terada, N. Kawamura, T. Toba, S. Nonoyama, H.D. Ochs, and A. Komiyama Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome J. Clin. Invest. 102 1998 853 860
3. H.L. Allen, and G.S. Deepe Jr. B cells and CD4-CD8- T cells are key regulators of the severity of reactivation histoplasmosis J. Immunol. 177 2006 1763 1771
4. R. Allendörfer, G.D. Brunner, and G.S. Deepe Jr. Complex requirements for nascent and memory immunity in pulmonary histoplasmosis J. Immunol. 162 1999 7389 7396
5. M. Alvarez, C. Saylor, and A. Casadevall Antibody action after phagocytosis promotes Cryptococcus neoformans and Cryptococcus gattii macrophage exocytosis with biofilm-like microcolony formation Cell. Microbiol. 10 2008 1622 1633
6. N. Baumgarth, J.W. Tung, and L.A. Herzenberg Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion Springer Semin. Immunopathol. 26 2005 347 362
7. D.O. Beenhouwer, S. Shapiro, M. Feldmesser, A. Casadevall, and M.D. Scharff Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans Infect. Immun. 69 2001 6445 6455
8. D.O. Beenhouwer, E.M. Yoo, C.W. Lai, M.A. Rocha, and S.L. Morrison Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection Infect. Immun. 75 2007 1424 1435
9. L. Berberian, L. Goodglick, T.J. Kipps, and J. Braun Immunoglobulin VH3 gene products: natural ligands for HIV gp120 Science 261 1993 1588 1591
10. L. Berberian, J. Shukla, R. Jefferis, and J. Braun Effects of HIV infection on VH3 (D12 idiotope) B cells in vivo J. Acquir. Immune Defic. Syndr. 7 1994 641 646
11. S. Brena, M.J. Omaetxebarría, N. Elguezabal, J. Cabezas, M.D. Moragues, and J. Pontón Fungicidal monoclonal antibody C7 binds to Candida albicans Als3 Infect. Immun. 75 2007 3680 3682
12. S. Brena, J. Cabezas-Olcoz, M.D. Moragues, I. Fernández de Larrinoa, A. Domínguez, G. Quindós, and J. Pontón Fungicidal monoclonal antibody C7 interferes with iron acquisition in Candida albicans Antimicrob. Agents Chemother. 55 2011 3156 3163
13. R.A. Bryan, A.J. Guimaraes, S. Hopcraft, Z. Jiang, K. Bonilla, A. Morgenstern, F. Bruchertseifer, M. Del Poeta, A. Torosantucci, and A. Cassone Toward Developing a Universal Treatment for Fungal Disease Using Radioimmunotherapy Targeting Common Fungal Antigens Mycopathologia 2011 in press
14. R. Buissa-Filho, R. Puccia, A.F. Marques, F.A. Pinto, J.E. Muñoz, J.D. Nosanchuk, L.R. Travassos, and C.P. Taborda The monoclonal antibody against the major diagnostic antigen of Paracoccidioides brasiliensis mediates immune protection in infected BALB/c mice challenged intratracheally with the fungus Infect. Immun. 76 2008 3321 3328
15. R. Calcedo, A. Ramirez-Garcia, A. Abad, A. Rementeria, J. Pontón, and F.L. Hernando Phosphoglycerate kinase and fructose bisphosphate aldolase of Candida albicans as new antigens recognized by human salivary IgA Rev. Iberoam. Micol. 2011 in press
16. A. Casadevall Antibody immunity and invasive fungal infections Infect. Immun. 63 1995 4211 4218
17. A. Casadevall, and L.A. Pirofski Antibody-mediated regulation of cellular immunity and the inflammatory response Trends Immunol. 24 2003 474 478
18. A. Casadevall, and L.A. Pirofski Accidental virulence, cryptic pathogenesis, martians, lost hosts, and the pathogenicity of environmental microbes Eukaryot. Cell 6 2007 2169 2174
19. A. Casadevall, and L.A. Pirofski A new synthesis for antibody-mediated immunity Nat. Immunol. 13 2011 21 28
20. A. Casadevall, E. Dadachova, and L.A. Pirofski Passive antibody therapy for infectious diseases Nat. Rev. Microbiol. 2 2004 695 703
21. A.K. Chaturvedi, A. Kavishwar, G.B. Shiva Keshava, and P.K. Shukla Monoclonal immunoglobulin G1 directed against Aspergillus fumigatus cell wall glycoprotein protects against experimental murine aspergillosis Clin. Diagn. Lab. Immunol. 12 2005 1063 1068
22. G.T. Cole, J.M. Xue, C.N. Okeke, E.J. Tarcha, V. Basrur, R.A. Schaller, R.A. Herr, J.J. Yu, and C.Y. Hung A vaccine against coccidioidomycosis is justified and attainable Med. Mycol. 42 2004 189 216
23. P.J. Costantino, N.F. Gare, and J.R. Warmington Humoral immune responses to systemic Candida albicans infection in inbred mouse strains Immunol. Cell Biol. 73 1995 125 133
24. M.B. da Silva, A.F. Marques, J.D. Nosanchuk, A. Casadevall, L.R. Travassos, and C.P. Taborda Melanin in the dimorphic fungal pathogen Paracoccidioides brasiliensis: effects on phagocytosis, intracellular resistance and drug susceptibility Microbes Infect. 8 2006 197 205
25. E. Dadachova, A. Nakouzi, R.A. Bryan, and A. Casadevall Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection Proc. Natl. Acad. Sci. USA 100 2003 10942 10947
26. F. De Bernardis, M. Boccanera, D. Adriani, E. Spreghini, G. Santoni, and A. Cassone Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats Infect. Immun. 65 1997 3399 3405
27. M. de Górgolas, A. Erice, A. Gil, J. Gutiérrez, P. Rivas, C. Hernando, and M.C. Rodríguez Cryptococcal meningitis in a patient with X-linked hyper-IgM1 syndrome Scand. J. Infect. Dis. 37 2005 526 528
28. M. Deshaw, and L.A. Pirofski Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals Clin. Exp. Immunol. 99 1995 425 432
29. S.J.N. Devi Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model Vaccine 14 1996 841 844
30. F. Dromer, J. Charreire, A. Contrepois, C. Carbon, and P. Yeni Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody Infect. Immun. 55 1987 749 752
31. F. Dromer, J. Salamero, A. Contrepois, C. Carbon, and P. Yeni Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide Infect. Immun. 55 1987 742 748
32. C.S. Farah, and R.B. Ashman Active and passive immunization against oral Candida albicans infection in a murine model Oral Microbiol. Immunol. 20 2005 376 381
33. M. Feldmesser, and A. Casadevall Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection J. Immunol. 158 1997 790 799
34. M. Feldmesser, A. Mednick, and A. Casadevall Antibody-mediated protection in murine Cryptococcus neoformans infection is associated with pleotrophic effects on cytokine and leukocyte responses Infect. Immun. 70 2002 1571 1580
35. R. Fleuridor, Z. Zhong, and L. Pirofski A human IgM monoclonal antibody prolongs survival of mice with lethal cryptococcosis J. Infect. Dis. 178 1998 1213 1216
36. R. Fleuridor, R.H. Lyles, and L. Pirofski Quantitative and qualitative differences in the serum antibody profiles of human immunodeficiency virus-infected persons with and without Cryptococcus neoformans meningitis J. Infect. Dis. 180 1999 1526 1535
37. R. Fleuridor, A. Lees, and L. Pirofski A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection J. Immunol. 166 2001 1087 1096
38. F. Gigliotti, and W.T. Hughes Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models J. Clin. Invest. 81 1988 1666 1668
39. F. Gigliotti, B.A. Garvy, and A.G. Harmsen Antibody-mediated shift in the profile of glycoprotein A phenotypes observed in a mouse model of Pneumocystis carinii pneumonia Infect. Immun. 64 1996 1892 1899
40. D.L. Goldman, H. Khine, J. Abadi, D.J. Lindenberg, Pirofski La, R. Niang, and A. Casadevall Serologic evidence for Cryptococcus neoformans infection in early childhood Pediatrics 107 2001 E66
41. D.L. Goldman, J. Davis, F. Bommarito, X. Shao, and A. Casadevall Enhanced allergic inflammation and airway responsiveness in rats with chronic Cryptococcus neoformans infection: potential role for fungal pulmonary infection in the pathogenesis of asthma J. Infect. Dis. 193 2006 1178 1186
42. D.O. Griffin, N.E. Holodick, and T.L. Rothstein Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70- J. Exp. Med. 208 2011 67 80
43. A.J. Guimarães, S. Frases, F.J. Gomez, R.M. Zancopé- Oliveira, and J.D. Nosanchuk Monoclonal antibodies to heat shock protein 60 alter the pathogenesis of Histoplasma capsulatum Infect. Immun. 77 2009 1357 1367
44. A.J. Guimarães, S. Frases, F.J. Gomez, R.M. Zancopé- Oliveira, and J.D. Nosanchuk Monoclonal antibodies to heat shock protein 60 alter the pathogenesis of Histoplasma capsulatum Infect. Immun. 77 2009 1357 1367
45. S. Gupta, M. Ellis, T. Cesario, M. Ruhling, and B. Vayuvegula Disseminated cryptococcal infection in a patient with hypogammaglobulinemia and normal T cell functions Am. J. Med. 82 1987 129 131
46. Y. Han, T. Kanbe, R. Cherniak, and J.E. Cutler Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies Infect. Immun. 65 1997 4100 4107
47. Y. Han, M.A. Ulrich, and J.E. Cutler Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis J. Infect. Dis. 179 1999 1477 1484
48. Y. Han, T.R. Kozel, M.X. Zhang, R.S. MacGill, M.C. Carroll, and J.E. Cutler Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis J. Immunol. 167 2001 1550 1557
49. Z. Jalali, L. Ng, N. Singh, and L.A. Pirofski Antibody response to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan in patients after solid-organ transplantation Clin. Vaccine Immunol. 13 2006 740 746
50. S.S. Kashino, R.A. Fazioli, C. Cafalli-Favati, L.H. Meloni-Bruneri, C.A. Vaz, E. Burger, L.M. Singer, and V.L. Calich Resistance to Paracoccidioides brasiliensis infection is linked to a preferential Th1 immune response, whereas susceptibility is associated with absence of IFN-gamma production J. Interferon Cytokine Res. 20 2000 89 97
51. H.M. Kling, T.W. Shipley, S.P. Patil, J. Kristoff, M. Bryan, R.C. Montelaro, A. Morris, and K.A. Norris Relationship of Pneumocystis jiroveci humoral immunity to prevention of colonization and chronic obstructive pulmonary disease in a primate model of HIV infection Infect. Immun. 78 2010 4320 4330
52. H.C. Lane, H. Masur, L.C. Edgar, G. Whalen, A.H. Rook, and A.S. Fauci Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome N. Engl. J. Med. 309 1983 453 458
53. R.A. Larsen, P.G. Pappas, J.R. Perfect, J.A. Aberg, A. Casadevall, G.A. Cloud, R. James, S. Filler, and W.E. Dismukes Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis Antimicrob. Agents Chemother. 49 2005 952 958
54. L.C. Lopes, A.J. Guimarães, M.D. de Cerqueira, B.L. Gómez, and J.D. Nosanchuk A histoplasma capsulatum-specific IgG1 isotype monoclonal antibody, H1C, to a 70-kilodalton cell surface protein is not protective in murine histoplasmosis Clin. Vaccine Immunol. 17 2010 1155 1158
55. L.C. Lopes, R. Rollin-Pinheiro, A.J. Guimarães, V.C. Bittencourt, L.R. Martinez, W. Koba, S.E. Farias, J.D. Nosanchuk, and E. Barreto-Bergter Monoclonal antibodies against peptidorhamnomannans of Scedosporium apiospermum enhance the pathogenicity of the fungus PLoS Negl. Trop. Dis. 4 2010 e853
56. J.A. Lovchik, J.A. Wilder, G.B. Huffnagle, R. Riblet, C.R. Lyons, and M.F. Lipscomb Ig heavy chain complex-linked genes influence the immune response in a murine cryptococcal infection J. Immunol. 163 1999 3907 3913
57. F.E. Lund, M. Hollifield, K. Schuer, J.L. Lines, T.D. Randall, and B.A. Garvy B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection J. Immunol. 176 2006 6147 6154
58. W. Magliani, S. Conti, R. Frazzi, L. Ravanetti, D.L. Maffei, and L. Polonelli Protective antifungal yeast killer toxin-like antibodies Curr. Mol. Med. 5 2005 443 452
59. G. Marquis, S. Montplaisir, M. Pelletier, S. Mousseau, and P. Auger Genetic resistance to murine cryptococcosis: increased susceptibility in the CBA/N XID mutant strain of mice Infect. Immun. 47 1985 282 287
60. K.A. Marr, K. Datta, L.A. Pirofski, and R. Barnes Cryptococcus gattii infection in healthy hosts: a sentinel for subclinical immunodeficiency? Clin. Infect. Dis. 54 2012 153 154
61. L.R. Martinez, and A. Casadevall Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy Infect. Immun. 73 2005 6350 6362
62. L.R. Martinez, D. Moussai, and A. Casadevall Antibody to Cryptococcus neoformans glucuronoxylomannan inhibits the release of capsular antigen Infect. Immun. 72 2004 3674 3679
63. L.R. Martinez, M.R. Mihu, A. Gácser, L. Santambrogio, and J.D. Nosanchuk Methamphetamine enhances histoplasmosis by immunosuppression of the host J. Infect. Dis. 200 2009 131 141
64. R.C. Matthews, J.P. Burnie, D. Howat, T. Rowland, and F. Walton Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis Immunology 74 1991 20 24
65. R.C. Matthews, G. Rigg, S. Hodgetts, T. Carter, C. Chapman, C. Gregory, C. Illidge, and J. Burnie Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90 Antimicrob. Agents Chemother. 47 2003 2208 2216
66. E.E. McClelland, A.M. Nicola, R. Prados-Rosales, and A. Casadevall Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism J. Clin. Invest. 120 2010 1355 1361
67. D.C. McFadden, B.C. Fries, F. Wang, and A. Casadevall Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans Eukaryot. Cell 6 2007 1464 1473
68. M.F. Miller, T.G. Mitchell, W.J. Storkus, and J.R. Dawson Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody Infect. Immun. 58 1990 639 645
69. S. Moir, and A.S. Fauci B cells in HIV infection and disease Nat. Rev. Immunol. 9 2009 235 245
70. C. Montagnoli, S. Bozza, A. Bacci, R. Gaziano, P. Mosci, J. Morschhäuser, L. Pitzurra, M. Kopf, J. Cutler, and L. Romani A role for antibodies in the generation of memory antifungal immunity Eur. J. Immunol. 33 2003 1193 1204
71. M.D. Moragues, M.J. Omaetxebarria, N. Elguezabal, M.J. Sevilla, S. Conti, L. Polonelli, and J. Pontón A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities Infect. Immun. 71 2003 5273 5279
72. J. Mukherjee, M.D. Scharff, and A. Casadevall Protective murine monoclonal antibodies to Cryptococcus neoformans Infect. Immun. 60 1992 4534 4541
73. N. Nabavi, and J.W. Murphy Antibody-dependent natural killer cell-mediated growth inhibition of Cryptococcus neoformans Infect. Immun. 51 1986 556 562
74. Rda.J. Neto, M.C. Guimarães, M.J. Moya, F.R. Oliveira, P.L. Louzada Jr., and R. Martinez Hypogammaglobulinemia as risk factor for Cryptococcus neoformans infection: report of 2 cases Rev. Soc. Bras. Med. Trop. 33 2000 603 608
75. J.D. Nosanchuk, J.N. Steenbergen, L. Shi, G.S. Deepe Jr., and A. Casadevall Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum J. Clin. Invest. 112 2003 1164 1175
76. G. Nussbaum, R. Yuan, A. Casadevall, and M.D. Scharff Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans J. Exp. Med. 183 1996 1905 1909
77. L.H. Okagaki, A.K. Strain, J.N. Nielsen, C. Charlier, N.J. Baltes, F. Chrétien, J. Heitman, F. Dromer, and K. Nielsen Cryptococcal cell morphology affects host cell interactions and pathogenicity PLoS Pathog. 6 2010 e1000953
78. J. Pachl, P. Svoboda, F. Jacobs, K. Vandewoude, B. van der Hoven, P. Spronk, G. Masterson, M. Malbrain, M. Aoun, J. Garbino, and J. Takala A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis Clin. Infect. Dis. 42 2006 1404 1413
79. L.A. Pirofski Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens Trends Microbiol. 9 2001 445 451
80. L. Pirofski, R. Lui, M. DeShaw, A.B. Kressel, and Z. Zhong Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine Infect. Immun. 63 1995 3005 3014
81. A.F. Popi, L.C. Godoy, P. Xander, J.D. Lopes, and M. Mariano B-1 cells facilitate Paracoccidioides brasiliensis infection in mice via IL-10 secretion Microbes Infect. 10 2008 817 824
82. R.R. Rapaka, D.M. Ricks, J.F. Alcorn, K. Chen, S.A. Khader, M. Zheng, S. Plevy, E. Bengtén, and J.K. Kolls Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina J. Exp. Med. 207 2010 2907 2919
83. J. Rivera, and A. Casadevall Mouse genetic background is a major determinant of isotype-related differences for antibody-mediated protective efficacy against Cryptococcus neoformans J. Immunol. 174 2005 8017 8026
84. J. Rivera, O. Zaragoza, and A. Casadevall Antibody-mediated protection against Cryptococcus neoformans is dependent on B cells Infect. Immun. 73 2005 1141 1150
85. M.L. Rodrigues, L.R. Travassos, K.R. Miranda, A.J. Franzen, S. Rozental, W. de Souza, C.S. Alviano, and E. Barreto-Bergter Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth Infect. Immun. 68 2000 7049 7060
86. A.L. Rosas, J.D. Nosanchuk, and A. Casadevall Passive immunization with melanin-binding monoclonal antibodies prolongs survival of mice with lethal Cryptococcus neoformans infection Infect. Immun. 69 2001 3410 3412
87. D.C. Saha, D.L. Goldman, X. Shao, A. Casadevall, S. Husain, A.P. Limaye, M. Lyon, J. Somani, K. Pursell, T.L. Pruett, and N. Singh Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients Clin. Vaccine Immunol. 14 2007 1550 1554
88. S. Sandini, R. La Valle, S. Deaglio, F. Malavasi, A. Cassone, and F. De Bernardis A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine FEMS Immunol. Med. Microbiol. 62 2011 215 224
89. J.E. Sanford, D.M. Lupan, A.M. Schlageter, and T.R. Kozel Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide Infect. Immun. 58 1990 1919 1923
90. S.P. Saville, A.L. Lazzell, A.K. Chaturvedi, C. Monteagudo, and J.L. Lopez-Ribot Use of a genetically engineered strain to evaluate the pathogenic potential of yeast cell and filamentous forms during Candida albicans systemic infection in immunodeficient mice Infect. Immun. 76 2008 97 102
91. A.M. Schlageter, and T.R. Kozel Opsonization of Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide Infect. Immun. 58 1990 1914 1918
92. S. Shapiro, D.O. Beenhouwer, M. Feldmesser, C. Taborda, M.C. Carroll, A. Casadevall, and M.D. Scharff Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3 Infect. Immun. 70 2002 2598 2604
93. L. Shi, P.C. Albuquerque, E. Lazar-Molnar, X. Wang, L. Santambrogio, A. Gácser, and J.D. Nosanchuk A monoclonal antibody to Histoplasma capsulatum alters the intracellular fate of the fungus in murine macrophages Eukaryot. Cell 7 2008 1109 1117
94. B.K. Sinha, S. Prasad, and D.P. Monga Studies of the role of B-cells in the resistance of mice to experimental candidiasis Zentralbl. Bakteriol. Mikrobiol. Hyg. [A] 266 1987 316 322
95. A.G. Smulian, D.W. Sullivan, and S.A. Theus Immunization with recombinant Pneumocystis carinii p55 antigen provides partial protection against infection: characterization of epitope recognition associated with immunization Microbes Infect. 2 2000 127 136
96. K. Subramaniam, B. Metzger, L.H. Hanau, A. Guh, L. Rucker, S. Badri, and L.A. Pirofski IgM(+) memory B cell expression predicts HIV-associated cryptococcosis status J. Infect. Dis. 200 2009 244 251
97. K.S. Subramaniam, K. Datta, M.S. Marks, and L.A. Pirofski Improved survival of mice deficient in secretory immunoglobulin M following systemic infection with Cryptococcus neoformans Infect. Immun. 78 2010 441 452
98. K.S. Subramaniam, K. Datta, E. Quintero, C. Manix, M.S. Marks, and L.A. Pirofski The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans J. Immunol. 184 2010 5755 5767
99. C.P. Taborda, J. Rivera, O. Zaragoza, and A. Casadevall More is not necessarily better: prozone-like effects in passive immunization with IgG J. Immunol. 140 2003 3621 3630
100. A. Torosantucci, C. Bromuro, P. Chiani, F. De Bernardis, F. Berti, C. Galli, F. Norelli, C. Bellucci, L. Polonelli, and P. Costantino A novel glyco-conjugate vaccine against fungal pathogens J. Exp. Med. 202 2005 597 606
101. A. Torosantucci, P. Chiani, C. Bromuro, F. De Bernardis, A.S. Palma, Y. Liu, G. Mignogna, B. Maras, M. Colone, and A. Stringaro Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence PLoS ONE 4 2009 e5392
102. A.B. van Spriel, J.H. Leusen, M. van Egmond, H.B. Dijkman, K.J. Assmann, T.N. Mayadas, and J.G. van de Winkel Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation Blood 97 2001 2478 2486
103. A.B. van Spriel, M. Sofi, K.H. Gartlan, A. van der Schaaf, I. Verschueren, R. Torensma, R.A. Raymakers, B.E. Loveland, M.G. Netea, and G.J. Adema The tetraspanin protein CD37 regulates IgA responses and anti-fungal immunity PLoS Pathog. 5 2009 e1000338
104. A. Viudes, A. Lazzell, S. Perea, W.R. Kirkpatrick, J. Peman, T.F. Patterson, J.P. Martinez, and J.L. López-Ribot The C-terminal antibody binding domain of Candida albicans mp58 represents a protective epitope during candidiasis FEMS Microbiol. Lett. 232 2004 133 138
105. J.A. Wahab, M.J. Hanifah, and K.E. Choo Bruton's agammaglobulinaemia in a child presenting with cryptococcal empyema thoracis and periauricular pyogenic abscess Singapore Med. J. 36 1995 686 689
106. J.A. Winkelstein, M.C. Marino, H. Ochs, R. Fuleihan, P.R. Scholl, R. Geha, E.R. Stiehm, and M.E. Conley The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients Medicine (Baltimore) 82 2003 373 384
107. H. Xin, and J.E. Cutler Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis Clin. Vaccine Immunol. 18 2011 1656 1667
108. H. Xin, S. Dziadek, D.R. Bundle, and J.E. Cutler Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis Proc. Natl. Acad. Sci. USA 105 2008 13526 13531
109. R.R. Yuan, A. Casadevall, J. Oh, and M.D. Scharff T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice Proc. Natl. Acad. Sci. USA 94 1997 2483 2488
110. R. Yuan, G. Spira, J. Oh, M. Paizi, A. Casadevall, and M.D. Scharff Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice Infect. Immun. 66 1998 1057 1062
111. O. Zaragoza, C.P. Taborda, and A. Casadevall The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions Eur. J. Immunol. 33 2003 1957 1967
112. O. Zaragoza, C.J. Chrisman, M.V. Castelli, S. Frases, M. Cuenca-Estrella, J.L. Rodríguez-Tudela, and A. Casadevall Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival Cell. Microbiol. 10 2008 2043 2057
113. O. Zaragoza, R. García-Rodas, J.D. Nosanchuk, M. Cuenca-Estrella, J.L. Rodríguez-Tudela, and A. Casadevall Fungal cell gigantism during mammalian infection PLoS Pathog. 6 2010 e1000945